|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/573 | |
| A61K 31/58 | |||
| C12Q 1/6883 | |||
| C12Q 1/6886 |
| (11) | Number of the document | 3143156 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15723409.7 |
| Date of filing the European patent application | 2015-05-07 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/029627 |
| Date | 2015-05-07 |
| (87) | Number | WO 2015/175305 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201461991710 P | 2014-05-12 | US |
| (72) |
SOKOL RICCI, Deborah, US
LI, Weimin, US
GORMLEY, Michael, US
KARKERA, Jayaprakash, US
SCHAFFER, Michael, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |
| BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |